Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Axsome Therapeutics (AXSM) Cost of Revenue (2022 - 2026)

Axsome Therapeutics' Cost of Revenue history spans 5 years, with the latest figure at $14.7 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 50.42% to $14.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $52.4 million, a 42.45% increase, with the full-year FY2025 number at $47.5 million, up 42.56% from a year prior.
  • Cost of Revenue hit $14.7 million in Q1 2026 for Axsome Therapeutics, up from $12.3 million in the prior quarter.
  • Over the last five years, Cost of Revenue for AXSM hit a ceiling of $14.7 million in Q1 2026 and a floor of $983000.0 in Q2 2022.
  • Historically, Cost of Revenue has averaged $7.9 million across 5 years, with a median of $7.8 million in 2023.
  • Biggest five-year swings in Cost of Revenue: surged 367.85% in 2023 and later dropped 16.66% in 2024.
  • Tracing AXSM's Cost of Revenue over 5 years: stood at $2.3 million in 2022, then soared by 222.04% to $7.4 million in 2023, then surged by 42.5% to $10.5 million in 2024, then grew by 17.26% to $12.3 million in 2025, then rose by 19.43% to $14.7 million in 2026.
  • Business Quant data shows Cost of Revenue for AXSM at $14.7 million in Q1 2026, $12.3 million in Q4 2025, and $11.9 million in Q3 2025.